BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14965713)

  • 1. Early detection of malignant process in benign lesions of breast tumor by measurements of changes in structuredness of cytoplasmic matrix in circulating lymphocytes (SCM test) reinduced in vitro by specific tumor antigen.
    Klein O; Linn S; Davidson C; Hadary A; Shukha A; Zidan J; Eitan A; Kook AI
    Breast; 2002 Dec; 11(6):478-83. PubMed ID: 14965713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach for high sensitivity detection of breast cancer by analysis of changes in structure of the cytoplasmic matrix of lymphocytes specifically induced by a specific breast tumour antigen (MUC-l/SEC).
    Klein O; Linn S; Hadari A; Davidson C; Eitan A; Zidan J; Kook AI
    Breast; 2002 Apr; 11(2):137-43. PubMed ID: 14965660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT.
    Klein O; Lin S; Embon O; Sazbon A; Zidan J; Kook AI
    J Urol; 1999 Jun; 161(6):1994-6. PubMed ID: 10332488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
    Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
    Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C; Hu L; Xia L; Li Y
    Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
    Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
    Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA.
    Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M
    Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
    Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
    Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).
    Manfrin E; Mariotto R; Remo A; Reghellin D; Falsirollo F; Dalfior D; Bricolo P; Piazzola E; Bonetti F
    Cancer; 2009 Feb; 115(3):499-507. PubMed ID: 19117040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics.
    Drukier AK; Ossetrova N; Schors E; Krasik G; Grigoriev I; Koenig C; Sulkowski M; Holcman J; Brown LR; Tomaszewski JE; Schnall MD; Sainsbury R; Lokshin AE; Godovac-Zimmermann J
    J Proteome Res; 2006 Aug; 5(8):1906-15. PubMed ID: 16889412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
    Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of some trace elements concentration in blood, tumor free breast and tumor tissues of women with benign and malignant breast lesions: an Indian study.
    Siddiqui MK; Jyoti ; Singh S; Mehrotra PK; Singh K; Sarangi R
    Environ Int; 2006 Jul; 32(5):630-7. PubMed ID: 16580070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity in ductal lavage for breast tumor and the contralateral breast.
    Yonekura Y; Yamamoto D; Okugawa H; Tanaka K; Kamiyama Y
    Oncol Rep; 2005 Apr; 13(4):739-43. PubMed ID: 15756451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
    Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MRI in screening women at high risk for breast cancer.
    Lehman CD
    J Magn Reson Imaging; 2006 Nov; 24(5):964-70. PubMed ID: 17036340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.